Accession Number: | 0000899243-19-017001 |
Date: | 2019-06-13 |
Issuer: | INFINITY PHARMACEUTICALS, INC. (INFI) |
Original Submission Date: |
KAUFFMAN MICHAEL
C/O INFINITY PHARMACEUTICALS, INC.
784 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.6 | 2019-06-13 | deemed execution date | A | 30,000 (a) | 2029-06-12 | common stock 30,000 | $1.60 | 30,000 | direct |
ID | footnote |
---|---|
f1 | the option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. |